1. Introduction {#s0005}
===============

Several manipulations were performed on the raw overlapping spectral data to enable mixture resolution, for example, using different order derivatives [@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], derivatives of the ratio spectrum [@bib7], [@bib8], [@bib9], [@bib10] and ratio subtraction technique [@bib11].

A new method ratio difference has been developed having the advantages of minimal data processing and wider range of application. The method was applied for the analysis of a mixture of brimonidine tartarate (Br) and timolol maleate (Ti) recently introduced into the markets.

2. Theory of the ratio difference method {#s0010}
========================================

Upon dividing the absorption spectrum of a compound by a spectrum of the same compound, a straight line of constant amplitude (parallel to the baseline) will result. However, upon dividing the absorption spectrum of a compound by the absorption spectrum of another compound, a new spectrum (ratio spectrum) will result ([Figure 1](#f0005){ref-type="fig"}, [Figure 2](#f0010){ref-type="fig"}).Figure 1The ratio spectrum of 20 μg/mL Br (**------**), 50 μg/mL Ti (- - -) and a mixture containing 20 μg/mL Br and 50 μg/mL Ti (**⋯**) using a divisor of 50 μg/mL Ti in distilled water.Figure 2The ratio spectrum of 20 μg/mL Br (**------**), 50 μg/mL Ti (- - -) and a mixture containing 20 μg/mL Br and 50 μg/mL Ti (**⋯**) using a divisor of 20 μg/mL Br in distilled water.

Mathematically it can be explained as follows:

In the ratio spectrum of a laboratory mixture of X and Y divided by a divisor Y′$$P_{1} = P_{1X} + K$$$$P_{2} = P_{2X} + K$$where *P*~1~ and *P*~2~ are the amplitudes of the mixture spectrum at *λ*~1~ and *λ*~2~, respectively. *P*~1X~ and *P*~2X~ are the amplitudes of X at *λ*~1~ and *λ*~2~, respectively, and *K* is the constant resulting from Y/Y′.$$\Delta P_{1–2} = P1–P2 = (P_{1X} + K)–(P_{2X} + K) = P_{1X} - P_{2X}$$

So the component Y will be completely cancelled and the difference will represent the X component only.

Component X in a binary mixture can be determined from a calibration curve that relates the difference in amplitudes (Δ*P*~1−2~) in the ratio spectrum at *λ*~1~ and *λ*~2~ using a certain concentration of Y as a divisor to the corresponding concentration of X. Similarly component Y can be obtained by using a certain concentration of X as a divisor.

3. Materials and method {#s0015}
=======================

SHIMADZU UV-1601 dual beam UV--visible spectrophotometer (Kyoto/Japan), Br and Ti reference standards (kindly supplied by Sigma Pharmaceutiacal Co. Cairo, Egypt), stock standard solution of 0.1 mg/mL Br and 0.1 mg/mL Ti in distilled water.

3.1. Procedures {#s0020}
---------------

### 3.1.1. Construction of calibration curves {#s0025}

The zero order spectra of different solutions of Br and Ti were divided by the spectra of 50 μg/mL Ti and 20 μg/mL Br, respectively. The difference in the peak amplitudes Δ*P* at the ratio spectra was measured at 260 and 290 nm (Δ*P*~260−290 nm~) for Br and at 295 and 330 nm (Δ*P*~295−330 nm~) for Ti. Calibration graphs relating Δ*P* at the chosen wavelength couples to the corresponding concentrations of Br and Ti were constructed, and the corresponding regression equations were computed.

### 3.1.2. Analysis of laboratory prepared mixtures {#s0030}

The zero order spectra of different laboratory prepared mixtures were divided by the spectrum of 50 μg/mL Ti (Δ*P*~260--290~ was recorded) and the spectrum of 20 μg/mL Br (Δ*P*~295--330 nm~ was recorded) for determination of Br and Ti, respectively.

### 3.1.3. Application of the proposed ratio difference method for the simultaneous determination of Br and Ti in Combigan ophthalmic solution {#s0035}

0.5 mL of the solution was transferred to another 100 mL measuring flask, and the volume was completed with distilled water. The concentrations of Br and Ti were obtained as in [Section 3.1.2.](#s0030){ref-type="sec"}

4. Results and discussion {#s0040}
=========================

The proposed ratio difference method can be applied for resolving absorption spectra of two components with high degree of overlap as in the case of Br and Ti ([Fig. 3](#f0015){ref-type="fig"}), where the application of the direct spectrophotometry failed to determine either of them in their mixture.Figure 3The absorption spectra of 20 μg/mL Br (**------**) and 50 μg/mL Ti (- - -) in distilled water.

The method comprises two critical steps, the first is the choice of the divisors, the selected divisors should compromise between minimal noise and maximum sensitivity. The divisor concentrations 50 μg/mL Ti and 20 μg/mL Br gave the best results regarding the average percentage recovery when used for the prediction of Br and Ti concentrations, respectively. The second critical step is the choice of the wavelengths at which measurements are recorded. Any two wavelengths can be chosen provided that they exhibit different amplitudes in the ratio spectrum and a good linearity is present at each wavelength individually.

Linear correlation was obtained between the differences in amplitude at 260 and 290 nm (Δ*P*~260--290 nm~) for Br and at 295 and 330 nm (Δ*P*~295--330 nm~) for Ti, against the corresponding concentrations of Br and Ti, respectively.

The proposed ratio difference method was applied for the determination of brimonidine and timolol in laboratory prepared mixtures ([Table 1](#t0005){ref-type="table"}), and in their pharmaceutical formulations ([Table 2](#t0010){ref-type="table"}). The suggested ratio difference method was validated according to USP guidelines [@bib12] and can be applied for routine quality control testing, as shown in [Table 3](#t0015){ref-type="table"}.Table 1Determination of Br and Ti in laboratory prepared mixtures by the proposed ratio difference method.Concentration (μg/mL)Recovery (%)BrTiBr Δ*P*~260--290~ ~nm~Ti Δ*P*~295--330 nm~10.0050.0096.52101.0620.0020.00100.75101.4220.0040.00100.43102.5320.0050.00100.82101.2325.0030.00103.33102.2630.0050.0099.5898.87Mean100.40101.23Std2.291.30RSD2.281.28Table 2Determination of Br and Ti in Combigan^®^ eye drops by the proposed ratio difference method and application of standard addition technique.Product in Combigan^®^ eye drop[a](#tbl2fna){ref-type="table-fn"}Standard additionRecovery (mean±SD, %)Taken (μg/mL)Added (μg/mL)Found (μg/mL)Recovery (%)Proposed methodStandard additionBr10.005.004.9398.60101.08±0.44100.10±1.4110.0010.14101.4020.0020.06100.30Ti25.0020.0020.15100.75100.66±0.52100.42±0.6825.0024.9199.6430.0030.26100.87[^1]Table 3Assay validation sheet of the proposed ratio difference method for the determination of Br and Ti.ParameterBrTiAccuracy (mean±SD)100.16±1.32100.17±1.66Specificity100.40±2.29101.23±1.30  PrecisionRepeatability[a](#tbl3fna){ref-type="table-fn"}100.21±0.73100.06±0.32Intermediate precision[b](#tbl3fnb){ref-type="table-fn"}100.07±0.40100.09±0.39  LinearitySlope0.07620.0811Intercept0.11050.0780Correlation coefficient *r*0.99990.9998Range (μg/mL)5--3010--60[^2][^3]

The suggested ratio difference method showed a wider range of application over the ratio subtraction method; it was able to determine both components in the binary mixture without limitations, whereas the ratio subtraction method [@bib11] failed to determine the component with the more extended spectrum (Br in this case).

Regarding simplicity, the proposed ratio difference method showed minimal data manipulation; instead of applying a certain order derivative in the derivative ratio method [@bib7], [@bib8], [@bib9], [@bib10] or subtraction of a constant and re-multiplication by the divisor in the ratio subtraction method, simply the following step will be calculating Δ*P* at any two wavelengths in the ratio spectrum.

Appendix A. Supplementary materials {#s0050}
===================================

Supplementary Material

Peer review under responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.jpha.2012.04.004](http://dx.doi.org/10.1016/j.jpha.2012.04.004).

[^1]: Combigan^®^ eye drops, batch no. E62201 labeled to contain 2 mg/mL of brimonidine tartarate and 5 mg/mL of timolol.

[^2]: The intraday (*n*=3), average of three concentrations (10, 15 and 20 μg/mL) for Br and (20, 30 and 40 μg/mL) for Ti repeated three times within the day.

[^3]: The interday (*n*=3), average of three concentrations (10, 15 and 20 μg/mL) for Br and (20, 30 and 40 μg/mL) for Ti repeated three times on three consecutive days.
